The relative clinical effectiveness of HFA-BDP and fluticasone propionate in asthma.
Fairfax
A J
AJ
Department of Thoracic Medicine, Staffordshire General Hospital, Stafford, UK.
D000287:Administration, Topical; D000335:Aerosol Propellants; D000730:Androstadienes / Q000627:therapeutic use*; D018927:Anti-Asthmatic Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001249:Asthma / Q000188:drug therapy*; D001507:Beclomethasone / Q000627:therapeutic use*; D002626:Chemistry, Pharmaceutical; D000068298:Fluticasone; D005938:Glucocorticoids; D006801:Humans; D006845:Hydrocarbons, Fluorinated; D005466:Fluorocarbons
D000335:Aerosol Propellants; D000730:Androstadienes; D018927:Anti-Asthmatic Agents; D000893:Anti-Inflammatory Agents; D001507:Beclomethasone; D000068298:Fluticasone; D005938:Glucocorticoids; D006845:Hydrocarbons, Fluorinated; C094049:apaflurane; D005466:Fluorocarbons